6DEP
Crystal structure of Candida albicans acetohydroxyacid synthase in complex with the herbicide sulfometuron methyl
6DEP の概要
エントリーDOI | 10.2210/pdb6dep/pdb |
分子名称 | Acetolactate synthase, FLAVIN-ADENINE DINUCLEOTIDE, POTASSIUM ION, ... (8 entities in total) |
機能のキーワード | ahas, acetohydroxyacid synthase, acetolactate synthase, herbicide, thiamin diphosphate, fad, transferase, sulfometuron methyl, sulfonylurea, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
由来する生物種 | Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast) |
タンパク質・核酸の鎖数 | 1 |
化学式量合計 | 76381.30 |
構造登録者 | |
主引用文献 | Garcia, M.D.,Chua, S.M.H.,Low, Y.S.,Lee, Y.T.,Agnew-Francis, K.,Wang, J.G.,Nouwens, A.,Lonhienne, T.,Williams, C.M.,Fraser, J.A.,Guddat, L.W. Commercial AHAS-inhibiting herbicides are promising drug leads for the treatment of human fungal pathogenic infections. Proc. Natl. Acad. Sci. U.S.A., 115:E9649-E9658, 2018 Cited by PubMed Abstract: The increased prevalence of drug-resistant human pathogenic fungal diseases poses a major threat to global human health. Thus, new drugs are urgently required to combat these infections. Here, we demonstrate that acetohydroxyacid synthase (AHAS), the first enzyme in the branched-chain amino acid biosynthesis pathway, is a promising new target for antifungal drug discovery. First, we show that several AHAS inhibitors developed as commercial herbicides are powerful accumulative inhibitors of AHAS ( values as low as 800 pM) and have determined high-resolution crystal structures of this enzyme in complex with several of these herbicides. In addition, we have demonstrated that chlorimuron ethyl (CE), a member of the sulfonylurea herbicide family, has potent antifungal activity against five different species and (with minimum inhibitory concentration, 50% values as low as 7 nM). Furthermore, in these assays, we have shown CE and itraconazole (a P450 inhibitor) can act synergistically to further improve potency. Finally, we show in -infected mice that CE is highly effective in clearing pathogenic fungal burden in the lungs, liver, and spleen, thus reducing overall mortality rates. Therefore, in view of their low toxicity to human cells, AHAS inhibitors represent a new class of antifungal drug candidates. PubMed: 30249642DOI: 10.1073/pnas.1809422115 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.149 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード